Metabolic syndrome and esophageal and gastric cancer.

Cancer Causes Control 2015 Dec 8;26(12):1825-34. Epub 2015 Oct 8.

Upper Gastrointestinal Surgery, Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76, Stockholm, Sweden.

Background: The role of the metabolic syndrome in the etiology of esophageal and gastric cancer is unclear.

Methods: This was a large nationwide cohort study based on data from 11 prospective population-based cohorts in Norway with long-term follow-up, the Cohort of Norway (CONOR) and the third Nord-Trøndelag Health Study (HUNT3). The metabolic syndrome was assessed by objective anthropometric and metabolic biochemical measures and was defined by the presence of at least three of the following five factors: increased waist circumference, elevated triglycerides, low high-density lipoprotein cholesterol, hypertension and high glucose. Newly diagnosed cases of esophageal adenocarcinoma, esophageal squamous-cell carcinoma and gastric adenocarcinoma were identified from the Norwegian Cancer Registry. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models with adjustment for potential confounders.

Result: Among 192,903 participants followed up for an average of 10.6 years, 62 developed esophageal adenocarcinoma, 64 had esophageal squamous-cell carcinoma and 373 had gastric adenocarcinoma. The metabolic syndrome was significantly associated with an increased risk of gastric adenocarcinoma (HR 1.44, 95% CI 1.14-1.82), but not associated with esophageal adenocarcinoma (HR 1.32, 95% CI 0.77-2.26) or esophageal squamous-cell carcinoma (HR 1.08, 95% CI 0.64-1.83). Increased waist circumference was associated with an increased HR of esophageal adenocarcinoma (HR 2.48, 95% CI 1.27-4.85). No significant association was found between any single component of the metabolic syndrome and risk of esophageal squamous-cell carcinoma. High waist circumference (HR 1.71, 95% CI 1.05-2.80), hypertension (HR 2.41, 95% CI 1.44-4.03) and non-fasting glucose (HR 1.74, 95% CI 1.18-2.56) were also related to an increased risk of gastric adenocarcinoma in women, but not in men.

Conclusion: Metabolic syndrome was associated with an increased risk of gastric adenocarcinoma in women. Of the individual components of the metabolic syndrome, high waist circumference was positively associated with risk of esophageal adenocarcinoma. Positive associations were also observed for women between high waist circumference, hypertension, high non-fasting glucose and risk of gastric adenocarcinoma. However, further evidence is warranted due to the limited number of cases and the inability to effectively identify gastric cardia adenocarcinoma.

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s10552-015-0675
Web Search
http://link.springer.com/10.1007/s10552-015-0675-4
Publisher Site
http://dx.doi.org/10.1007/s10552-015-0675-4DOI Listing
December 2015
19 Reads

Publication Analysis

Top Keywords

metabolic syndrome
28
gastric adenocarcinoma
24
esophageal adenocarcinoma
20
waist circumference
20
squamous-cell carcinoma
16
risk gastric
16
esophageal squamous-cell
16
high waist
12
adenocarcinoma
12
increased risk
12
associated increased
12
esophageal
11
gastric
9
95%
8
non-fasting glucose
8
syndrome associated
8
risk esophageal
8
hypertension high
8
esophageal gastric
8
metabolic
8

References

(Supplied by CrossRef)

J Ferlay et al.
Int J Cancer 2010

KG Alberti et al.
Circulation 2009

ES Ford et al.
J Diabetes 2010

A Zanchetti et al.
J Hypertens 2007

J Escobedo et al.
Cardiovasc Diabetol 2009

JL Beebe-Dimmer et al.
Urology 2009

AW Hsing et al.
Am J Clin Nutr 2007

F Turati et al.
Br J Cancer 2013

C Haggstrom et al.
Int J Cancer 2011

V Rosato et al.
Ann Oncol 2011

E Giovannucci et al.
Am J Clin Nutr 2007

Similar Publications